ChemoCentryx
CCXI
#3554
Rank
HK$29.09 B
Marketcap
HK$404.59
Share price
0.00%
Change (1 day)
33.76%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI)

Last known market cap: HK$29.09 Billion

On November 25, 2022 ChemoCentryx had a market cap of HK$29.09 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022HK$29.21 B46.94%
2021HK$19.88 B-40.15%
2020HK$33.22 B79.06%
2019HK$18.55 B328.74%
2018HK$4.32 B90.89%
2017HK$2.26 B-17.36%
2016HK$2.74 B-1.11%
2015HK$2.77 B20.52%
2014HK$2.30 B19.53%
2013HK$1.92 B-37.54%
2012HK$3.08 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Biogen
BIIB
HK$200.88 B 590.37%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$3.064 T 10,430.27%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$745.79 B 2,463.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
HK$802.73 B 2,658.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$3.751 T 12,793.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$1.315 T 4,420.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.121 T 3,755.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$255.52 B 778.16%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
HK$1.882 T 6,369.40%๐Ÿ‡บ๐Ÿ‡ธ USA